This type of rosacea may occur alone or with ETR type. Common treatments for PPR include: Ocular rosacea affects your eyes ...

Tarsus Pharmaceuticals, Inc. has announced plans to advance TP-04, an investigational ophthalmic gel formulation of lotilaner, for the treatment of Ocular Rosacea, a significant but currently ...

“My job as a dermatologist is to diagnose and treat the rosacea, uncover any potential comorbidities, and refer back to the primary care giver,” she added. “The last thing that I want to do ...

Moreover, Tarsus is extending its reach into ocular rosacea, a condition with no FDA-approved treatments, by advancing TP-04 into a Phase 2 study. The potential for TP-04 to address a significant ...

State Medicaid formularies demonstrate significant variability in rosacea treatment coverage, with only 10% of states offering unrestricted access to basic therapeutic options, in an analysis of ...

The commentary focused on Tarsus Pharmaceuticals' impressive sales figures for their product XDEMVY, particularly highlighting its potential in treating ocular rosacea. The company has ...

The commentary focused on Tarsus Pharmaceuticals' impressive sales figures for their product XDEMVY, particularly highlighting its potential in treating ocular rosacea. The company has demonstrated ...